Suneva Medical

Suneva Medical, Inc., founded in 2009 and based in San Diego, California, operates as a commercial-stage medical technology company with a focus on the regenerative aesthetics market. The company develops, manufactures, and commercializes a portfolio of products for physicians and their patients, designed to leverage the body's own restorative capabilities. The business generates revenue by selling its aesthetic products to providers in the dermatology, plastic, and cosmetic surgery markets.

The company's product portfolio has included several notable offerings. Its flagship product, Bellafill®, is a dermal filler with FDA approval for correcting nasolabial folds (smile lines) and moderate to severe, atrophic, distensible facial acne scars on the cheeks. In January 2019, Suneva expanded its regenerative aesthetics portfolio through partnerships with Healeon Medical and Puregraft, LLC, adding innovative PRP (platelet-rich plasma) technology and a fat grafting system. Later, the portfolio grew to include Silhouette Instalift®, resorbable sutures for cosmetic facial procedures, and PlasmaIQ™, a hand-held plasma energy device. However, in October 2024, Tiger Aesthetics Medical, LLC, a division of Tiger BioSciences, acquired select assets from Suneva, including the BellaFill®, Silhouette InstaLift®, and Amplifine™ PRP product lines.

Suneva Medical has a history of significant leadership changes and financing rounds to support its growth. Nicholas L. Teti Jr. served as Chairman and CEO for six years, overseeing the FDA approval of Bellafill for acne scars. In August 2016, Preston Romm was promoted to President and CEO. Patricia Altavilla, a seasoned executive with over 30 years in the aesthetics and medical fields, was appointed CEO in March 2019, succeeding Romm. Her extensive background includes leadership roles at Mentor Corporation, BioForm Medical (now Merz Aesthetics), and ZELTIQ® Aesthetics. The company has secured substantial funding over the years, including a $35 million round in 2014, a $25 million investment from Essex Woodlands in 2016, and has been backed by investors like Polaris Partners, EW Healthcare Partners, and Almirall. In January 2022, Suneva announced a definitive merger agreement with Viveon Health Acquisition Corp., a special purpose acquisition company (SPAC), with plans to trade on the NYSE under the symbol "RNEW", although the deal was later noted as cancelled. Keywords: regenerative aesthetics, medical aesthetics, dermal fillers, Bellafill, Silhouette Instalift, PlasmaIQ, Puregraft, aesthetic medicine, non-surgical aesthetics, cosmetic surgery products, dermatology devices, fat grafting, platelet-rich plasma, biostimulatory filler, acne scar treatment, facial rejuvenation, medical technology, aesthetics market, nasolabial folds correction, collagen stimulation